Department of Neurosurgery
Ana C. deCarvalho has not added Biography.
If you are Ana C. deCarvalho and would like to personalize this page please email our Author Liaison for assistance.
A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
Molecular medicine (Cambridge, Mass.) Feb, 2002 | Pubmed ID: 12080183
Mutations in the nucleotide binding domain 1 signature motif region rescue processing and functional defects of cystic fibrosis transmembrane conductance regulator delta f508.
The Journal of biological chemistry Sep, 2002 | Pubmed ID: 12110684
Retina-specific expression of 5A11/Basigin-2, a member of the immunoglobulin gene superfamily.
Investigative ophthalmology & visual science Sep, 2003 | Pubmed ID: 12939332
Developmental expression of the POU domain transcription factor Brn-3b (Pou4f2) in the lateral line and visual system of zebrafish.
Developmental dynamics : an official publication of the American Association of Anatomists Apr, 2004 | Pubmed ID: 15042710
SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.
Cancer letters May, 2006 | Pubmed ID: 15967572
EphB2 induces proliferation and promotes a neuronal fate in adult subventricular neural precursor cells.
Neuroscience letters Sep, 2005 | Pubmed ID: 15970380
Low-dose photodynamic therapy increases endothelial cell proliferation and VEGF expression in nude mice brain.
Lasers in medical science Sep, 2005 | Pubmed ID: 16096716
Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth.
Glia Aug, 2007 | Pubmed ID: 17551928
Heparanase expression of glioma in human and animal models.
Journal of neurosurgery Aug, 2010 | Pubmed ID: 19835469
Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.
Stem cells (Dayton, Ohio) Feb, 2010 | Pubmed ID: 19937755
Development of a novel animal model to differentiate radiation necrosis from tumor recurrence.
Journal of neuro-oncology Jul, 2012 | Pubmed ID: 22407176
Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations.
Cancer research Dec, 2013 | Pubmed ID: 24346432
Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
Neoplasia (New York, N.Y.) Mar, 2014 | Pubmed ID: 24726753
Optimization of Glioblastoma Mouse Orthotopic Xenograft Models for Translational Research.
Comparative medicine Aug, 2017 | Pubmed ID: 28830577
Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma.
Nature genetics May, 2018 | Pubmed ID: 29686388
Clinical and research applications of a brain tumor tissue bank in the age of precision medicine.
Personalized medicine Mar, 2019 | Pubmed ID: 30816054
A serum-based DNA methylation assay provides accurate detection of glioma.
Neuro-oncology Sep, 2021 | Pubmed ID: 33560371
DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features.
Neuro-oncology Aug, 2021 | Pubmed ID: 33631002
Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors.
Neuro-oncology Jul, 2022 | Pubmed ID: 35212383
Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas.
Nature communications Sep, 2023 | Pubmed ID: 37704607
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen.
Cancer research Mar, 2024 | Pubmed ID: 38117484
Bryan D. Kim1,2,
Sujan K. Mondal1,3,
Elizabeth Kenyon1,3,
Ming Chen1,3,
Christiane L. Mallett3,4,
Ana C. deCarvalho5,
Zdravka Medarova6,
Anna Moore1,3
1Precision Health Program, Michigan State University,
2Department of Biomedical Engineering, College of Engineering, Michigan State University,
3Department of Radiology, College of Human Medicine, Michigan State University,
4Institute for Quantitative Health Science and Engineering, Michigan State University,
5, Henry Ford Health,
6, Transcode Therapeutics Inc.
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados